JP2016013980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016013980A5 JP2016013980A5 JP2014135762A JP2014135762A JP2016013980A5 JP 2016013980 A5 JP2016013980 A5 JP 2016013980A5 JP 2014135762 A JP2014135762 A JP 2014135762A JP 2014135762 A JP2014135762 A JP 2014135762A JP 2016013980 A5 JP2016013980 A5 JP 2016013980A5
- Authority
- JP
- Japan
- Prior art keywords
- film
- coated tablet
- tablet according
- light
- coating layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014135762A JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014135762A JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016013980A JP2016013980A (ja) | 2016-01-28 |
| JP2016013980A5 true JP2016013980A5 (enExample) | 2017-07-13 |
| JP6440294B2 JP6440294B2 (ja) | 2018-12-19 |
Family
ID=55230496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014135762A Expired - Fee Related JP6440294B2 (ja) | 2014-07-01 | 2014-07-01 | テルミサルタン含有フィルムコーティング錠剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6440294B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6132858B2 (ja) * | 2015-01-09 | 2017-05-24 | ダイト株式会社 | テルミサルタン含有フィルムコート錠 |
| JP2020094024A (ja) * | 2018-12-14 | 2020-06-18 | エルメッド株式会社 | レベチラセタム含有フィルムコート錠及びその製造方法、並びにレベチラセタム含有フィルムコート錠の変色抑制方法 |
| JP7262005B2 (ja) * | 2019-01-25 | 2023-04-21 | 日本ジェネリック株式会社 | シロドシン含有固形組成物及びその製造法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4016128B2 (ja) * | 1999-09-09 | 2007-12-05 | 東和薬品株式会社 | 耐光性塩酸エピナスチンフィルムコート錠 |
| DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
| JP3496832B1 (ja) * | 2002-12-27 | 2004-02-16 | 小野薬品工業株式会社 | コーティング製剤およびその製造方法 |
| JP4675751B2 (ja) * | 2005-11-04 | 2011-04-27 | 東和薬品株式会社 | アムロジピンを含有する安定化された医薬品組成物 |
| JPWO2008114859A1 (ja) * | 2007-03-22 | 2010-07-08 | アステラス製薬株式会社 | ピラゾール誘導体を含有する医薬組成物 |
| EP2612658A1 (en) * | 2012-01-05 | 2013-07-10 | Laboratorios Lesvi, S.L. | Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
-
2014
- 2014-07-01 JP JP2014135762A patent/JP6440294B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016518337A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| EP3565550A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| JP2017506627A5 (enExample) | ||
| EP3621621A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| JP2015147774A5 (enExample) | ||
| JP2015513557A5 (enExample) | ||
| EA201792290A1 (ru) | Таблетка, содержащая рибоциклиб | |
| JP2014507446A5 (enExample) | ||
| JP2014218522A5 (enExample) | ||
| MX389178B (es) | Formulacion de proporcion fija de insulina glargina/lixisenatida. | |
| EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
| EP3333223A4 (en) | COMPOSITION, COATING FILM, FLUOROUS COATING FILM AND LAMINATE | |
| MX380566B (es) | Composición oral que comprende una primera población de microesferas con un ingrediente activo susceptible o con potencial de abuso y una segunda población de microesferas con óxido de polietileno y un recubrimiento permeable o semipermeable. | |
| EP3103802A4 (en) | Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect | |
| JP2017531686A5 (enExample) | ||
| NZ611026A (en) | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria | |
| JP2018118936A5 (enExample) | ||
| JP2016013980A5 (enExample) | ||
| JP2015508411A5 (enExample) | ||
| JP2016513680A5 (enExample) | ||
| AR092356A1 (es) | Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion | |
| JP2016507627A5 (enExample) | ||
| ECSP16005208A (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| WO2016020408A3 (en) | Compounds for preventing ototoxicity |